Joint guidance for asthma recommends replacing SABA with corticosteroid inhalers

The draft guidance proposes the use of combined inhaled corticosteroid/formoterol inhalers over previously preferred short-acting beta agonists.
Young boy using inhaler with spacer
In children aged 5–11 years newly diagnosed with asthma, twice-daily paediatric low-dose inhaled corticosteroid is advised, with a SABA as needed, followed by paediatric low-dose maintenance and reliever therapy for further control

Shutterstock.com

Draft guidance for the diagnosis, monitoring and management of chronic asthma has recommended several changes to current clinical practice in the UK.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated